Obesity and Insulin Resistance in Asthma Pathogenesis and Clinical Outcomes.

asthma challenges inflammation insulin resistance obesity therapeutic options

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
12 Jan 2024
Historique:
received: 19 12 2023
revised: 10 01 2024
accepted: 11 01 2024
medline: 23 1 2024
pubmed: 23 1 2024
entrez: 23 1 2024
Statut: epublish

Résumé

Common inflammatory ground links obesity, insulin resistance, and asthma. As recognition of their interplay, one worsening the natural course of the other, is recognised, questions remain about how to adequately address them altogether to improve clinical outcomes. The present manuscript sheds light on the problem, describing possible pathophysiological links, clinical views, and therapeutic challenges, raising questions about what remains to be done, and calling for multidisciplinary treatment of these patients to detect diseases early and adequately address them before they become full-blown and deteriorate their health and quality of life.

Identifiants

pubmed: 38255279
pii: biomedicines12010173
doi: 10.3390/biomedicines12010173
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Auteurs

Sabina Škrgat (S)

Department of Pulmonary Diseases and Allergy, University Medical Centre Ljubljana, SI-1000 Ljubljana, Slovenia.
Medical Faculty, University of Ljubljana, SI-1000 Ljubljana, Slovenia.

Matevž Harlander (M)

Department of Pulmonary Diseases and Allergy, University Medical Centre Ljubljana, SI-1000 Ljubljana, Slovenia.
Medical Faculty, University of Ljubljana, SI-1000 Ljubljana, Slovenia.

Miodrag Janić (M)

Medical Faculty, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Clinical Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, SI-1000 Ljubljana, Slovenia.

Classifications MeSH